Potential utility of FGFR2 mutation status as an adverse prognostic factor to affect clinical decision-making.

The decision tree is adapted from 2011 National Comprehensive Cancer Network guidelines using FIGO 2009 staging. BT = brachytherapy; RT = radiation therapy.